Genetic Variants
Genetic Variants - Related Videos
01:27
Principles of Pharmacogenetics: Types of Genetic Variants
0 Views •
2026
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
0 Views •
Cited by 15 •
2016
We present a strategic plan and protocol for identifying non-coding genetic variants affecting transcription factor (TF) DNA binding. A detailed experimental protocol is provided for electrophoretic mobility shift assay (EMSA) and DNA affinity precipitation assay (DAPA) analysis of genotype-dependent TF DNA binding.
14:06
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
0 Views •
Cited by 10 •
2012
Pooled DNA sequencing is a fast and cost-effective strategy to detect rare variants associated with complex phenotypes in large cohorts. Here we describe the computational analysis of pooled, next-generation sequencing of 32 cancer-related genes using the SPLINTER software package. This method is scalable, and applicable to any phenotype of interest.
08:46
Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
0 Views •
Cited by 2 •
2020
High resolution melting analysis (HRM) is a sensitive and rapid solution for genetic variant detection. It depends on sequence differences that result in heteroduplexes changing the shape of the melting curve. By combing HRM and agarose gel electrophoresis, different types of genetic variants such as indels can be identified.
15:49
Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
0 Views •
Cited by 1 •
2022
The protocol describes a method for introducing controllable genetic diversity in the hepatitis C virus genome by combining full-length mutant RNA synthesis using error-prone PCR and reverse genetics. The method provides a model for phenotype selection and can be used for 10 kb long positive-sense RNA virus genomes.
FAQs
The consequence depends partly on the sequence change and where it occurs. A nucleotide substitution may change protein structure or gene regulation, while an insertion, deletion, or duplication can affect the encoded sequence or chromosome function. These effects provide a mechanistic basis for differences in biological traits, disease susceptibility, or response to treatment.
Its clinical significance requires evidence beyond detecting a sequence difference. Interpretation can incorporate comparison with a reference genome, the variant’s frequency in populations, and available clinical evidence. This process helps distinguish pathogenic changes associated with disease from benign variation that occurs without a clinically meaningful effect.
Treatment response may be influenced when a variant changes protein structure, gene regulation, or another aspect of chromosome function relevant to biology. Clinical interpretation therefore considers the observed sequence change together with supporting clinical evidence. Identifying such relationships can help connect sequence data with differences in how individuals respond to treatment.
Clinical investigations may analyze blood, tissue, or other biological samples to obtain sequence information. The selected sample provides the material for identifying DNA differences, which are then evaluated against a reference genome and other evidence. This workflow supports studies of disease-associated changes, inherited risk, diagnosis, and treatment-related questions.
Analysis begins by comparing sequence data with a reference genome to identify differences. Investigators then consider population frequencies and clinical evidence to assess whether a finding is associated with disease or represents benign variation. The resulting interpretation is more informative than a list of sequence changes because it connects detected variants with their possible clinical significance.
Variant analysis can contribute to identifying disease-associated changes, supporting diagnosis, estimating inherited risk, and guiding precision medicine. Its value depends on careful interpretation rather than detection alone. By integrating sequence findings with reference information, population data, and clinical evidence, researchers and clinicians can better evaluate whether a result has practical relevance for an individual.